XORTX’s board of directors accepted the resignation of the Former Auditor, as of January 16, 2025 and appointed the Successor Auditor as the new auditor of the Company effective January 16, 2025, and ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

Shingles is an infection that causes a painful, itchy rash on one side of the face or body. Before the rash appears, you may ...

Rich in antioxidants, green tea reduces uric acid production and inflammation. Replace sugary drinks with green tea for better results. Promotes detoxification and helps balance uric acid levels. Mix ...

The story of how a little village near Dunstable became a place of pilgrimage was told by Stephen William to members of the ...

A recent study highlights a surprising issue for people living with gout in the United States: most gout flares are never ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

The global intravenous pegloticase market is poised for substantial growth, projected to reach USD 11.61 Billion by 2033 from ...

With the clinical development of XORLO TM1 having advanced sufficiently, including completion of a pivotal program, XORTX is initiating discussions for the XRx-026 program with the US Food and Drug ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...